APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Vaccine for Non-infectious Meningitis

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Vaccine for Non-infectious Meningitis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174044820322 December 2025188 pages

Choose your research edition.

Industry ResearchVaccine for Non-infectious Meningitis Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine for Non-infectious Meningitis Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Vaccine for Non-infectious Meningitis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine for Non-infectious Meningitis Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccine for Non-infectious Meningitis Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Vaccine for Non-infectious Meningitis market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Vaccine for Non-infectious Meningitis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vaccine for Non-infectious Meningitis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaccine for Non-infectious Meningitis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Vaccine for Non-infectious Meningitis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vaccine for Non-infectious Meningitis include JN-International Medical, Nuron Biotech, Serum Institute, Pfizer and Sanofi SA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vaccine for Non-infectious Meningitis market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vaccine for Non-infectious Meningitis and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vaccine for Non-infectious Meningitis sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vaccine for Non-infectious Meningitis market size, projected growth trends, production technologies, key applications, and end-use industries.

Vaccine for Non-infectious Meningitis Segment by Company

JN-International Medical

Nuron Biotech

Serum Institute

Pfizer

Sanofi SA

Vaccine for Non-infectious Meningitis Segment by Type

Men B Vaccines

Combination Vaccines

Conjugate Vaccines

Polysaccharide Vaccines

Vaccine for Non-infectious Meningitis Segment by Application

Meningitis

Septicemia

Others

Vaccine for Non-infectious Meningitis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine for Non-infectious Meningitis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine for Non-infectious Meningitis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine for Non-infectious Meningitis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vaccine for Non-infectious Meningitis market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vaccine for Non-infectious Meningitis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Vaccine for Non-infectious Meningitis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Vaccine for Non-infectious Meningitis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Vaccine for Non-infectious Meningitis Industry Trends Table 2. Vaccine for Non-infectious Meningitis Industry Drivers Table 3. Vaccine for Non-infectious Meningitis Industry Opportunities and Challenges Table 4. Vaccine for Non-infectious Meningitis Industry Restraints Table 5. Global Vaccine for Non-infectious Meningitis Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Vaccine for Non-infectious Meningitis Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Vaccine for Non-infectious Meningitis Sales Market Share by Manufacturers Table 9. Global Vaccine for Non-infectious Meningitis Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Vaccine for Non-infectious Meningitis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Vaccine for Non-infectious Meningitis Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Vaccine for Non-infectious Meningitis Manufacturers, Product Type & Application Table 13. Global Vaccine for Non-infectious Meningitis Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Vaccine for Non-infectious Meningitis by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Men B Vaccines Table 17. Major Manufacturers of Combination Vaccines Table 18. Major Manufacturers of Conjugate Vaccines Table 19. Major Manufacturers of Polysaccharide Vaccines Table 20. Global Vaccine for Non-infectious Meningitis Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Vaccine for Non-infectious Meningitis Sales by Type (2021-2026) & (k units) Table 22. Global Vaccine for Non-infectious Meningitis Sales by Type (2027-2032) & (k units) Table 23. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2021-2026) Table 24. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2027-2032) Table 25. Global Vaccine for Non-infectious Meningitis Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Vaccine for Non-infectious Meningitis Revenue by Type (2021-2026) & (k units) Table 27. Global Vaccine for Non-infectious Meningitis Revenue by Type (2027-2032) & (k units) Table 28. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2021-2026) Table 29. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Meningitis Table 31. Major Manufacturers of Septicemia Table 32. Major Manufacturers of Others Table 33. Global Vaccine for Non-infectious Meningitis Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Vaccine for Non-infectious Meningitis Sales by Application (2021-2026) & (k units) Table 35. Global Vaccine for Non-infectious Meningitis Sales by Application (2027-2032) & (k units) Table 36. Global Vaccine for Non-infectious Meningitis Sales Market Share by Application (2021-2026) Table 37. Global Vaccine for Non-infectious Meningitis Sales Market Share by Application (2027-2032) Table 38. Global Vaccine for Non-infectious Meningitis Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Vaccine for Non-infectious Meningitis Revenue by Application (2021-2026) & (k units) Table 40. Global Vaccine for Non-infectious Meningitis Revenue by Application (2027-2032) & (k units) Table 41. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2021-2026) Table 42. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2027-2032) Table 43. Global Vaccine for Non-infectious Meningitis Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Vaccine for Non-infectious Meningitis Sales by Region (2021-2026) & (k units) Table 45. Global Vaccine for Non-infectious Meningitis Sales Market Share by Region (2021-2026) Table 46. Global Vaccine for Non-infectious Meningitis Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Vaccine for Non-infectious Meningitis Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Vaccine for Non-infectious Meningitis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Vaccine for Non-infectious Meningitis Sales by Country (2021-2026) & (k units) Table 50. North America Vaccine for Non-infectious Meningitis Sales by Country (2027-2032) & (k units) Table 51. Europe Vaccine for Non-infectious Meningitis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Vaccine for Non-infectious Meningitis Sales by Country (2021-2026) & (k units) Table 53. Europe Vaccine for Non-infectious Meningitis Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Vaccine for Non-infectious Meningitis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Vaccine for Non-infectious Meningitis Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Vaccine for Non-infectious Meningitis Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Vaccine for Non-infectious Meningitis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Vaccine for Non-infectious Meningitis Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Vaccine for Non-infectious Meningitis Sales by Country (2027-2032) & (k units) Table 60. Global Vaccine for Non-infectious Meningitis Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Vaccine for Non-infectious Meningitis Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Vaccine for Non-infectious Meningitis Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2021-2026) Table 64. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2027-2032) Table 65. JN-International Medical Company Information Table 66. JN-International Medical Business Overview Table 67. JN-International Medical Vaccine for Non-infectious Meningitis Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. JN-International Medical Vaccine for Non-infectious Meningitis Product Portfolio Table 69. JN-International Medical Recent Development Table 70. Nuron Biotech Company Information Table 71. Nuron Biotech Business Overview Table 72. Nuron Biotech Vaccine for Non-infectious Meningitis Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Nuron Biotech Vaccine for Non-infectious Meningitis Product Portfolio Table 74. Nuron Biotech Recent Development Table 75. Serum Institute Company Information Table 76. Serum Institute Business Overview Table 77. Serum Institute Vaccine for Non-infectious Meningitis Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Serum Institute Vaccine for Non-infectious Meningitis Product Portfolio Table 79. Serum Institute Recent Development Table 80. Pfizer Company Information Table 81. Pfizer Business Overview Table 82. Pfizer Vaccine for Non-infectious Meningitis Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Pfizer Vaccine for Non-infectious Meningitis Product Portfolio Table 84. Pfizer Recent Development Table 85. Sanofi SA Company Information Table 86. Sanofi SA Business Overview Table 87. Sanofi SA Vaccine for Non-infectious Meningitis Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Sanofi SA Vaccine for Non-infectious Meningitis Product Portfolio Table 89. Sanofi SA Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Vaccine for Non-infectious Meningitis Distributors List Table 93. Vaccine for Non-infectious Meningitis Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Vaccine for Non-infectious Meningitis Product Image Figure 2. Global Vaccine for Non-infectious Meningitis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccine for Non-infectious Meningitis Market Size (2021-2032) & (US$ Million) Figure 4. Global Vaccine for Non-infectious Meningitis Sales (2021-2032) & (k units) Figure 5. Global Vaccine for Non-infectious Meningitis Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Vaccine for Non-infectious Meningitis Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Men B Vaccines Image Figure 9. Combination Vaccines Image Figure 10. Conjugate Vaccines Image Figure 11. Polysaccharide Vaccines Image Figure 12. Global Vaccine for Non-infectious Meningitis Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Vaccine for Non-infectious Meningitis Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2021-2032) Figure 15. Global Vaccine for Non-infectious Meningitis Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Vaccine for Non-infectious Meningitis Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2021-2032) Figure 18. Meningitis Image Figure 19. Septicemia Image Figure 20. Others Image Figure 21. Global Vaccine for Non-infectious Meningitis Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Vaccine for Non-infectious Meningitis Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Vaccine for Non-infectious Meningitis Sales Market Share by Application (2021-2032) Figure 24. Global Vaccine for Non-infectious Meningitis Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Vaccine for Non-infectious Meningitis Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2021-2032) Figure 27. North America Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Vaccine for Non-infectious Meningitis Sales Market Share by Country (2021-2032) Figure 29. U.S. Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Country (2021-2032) Figure 34. Germany Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Vaccine for Non-infectious Meningitis Sales Market Share by Country (2021-2032) Figure 41. China Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Vaccine for Non-infectious Meningitis Sales Market Share by Country (2021-2032) Figure 49. Brazil Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Vaccine for Non-infectious Meningitis Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Vaccine for Non-infectious Meningitis Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Vaccine for Non-infectious Meningitis Revenue (2021-2032) & (US$ Million) Figure 60. North America Vaccine for Non-infectious Meningitis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Vaccine for Non-infectious Meningitis Revenue (2021-2032) & (US$ Million) Figure 62. Europe Vaccine for Non-infectious Meningitis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Vaccine for Non-infectious Meningitis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Vaccine for Non-infectious Meningitis Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Vaccine for Non-infectious Meningitis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Vaccine for Non-infectious Meningitis Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Vaccine for Non-infectious Meningitis Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Men B Vaccines
  • Combination Vaccines
  • Conjugate Vaccines
  • Polysaccharide Vaccines
Applications
  • Meningitis
  • Septicemia
  • Others
Companies covered
  • JN-International Medical
  • Nuron Biotech
  • Serum Institute
  • Pfizer
  • Sanofi SA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Vaccine for Non-infectious Meningitis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Vaccine for Non-infectious Meningitis Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Vaccine for Non-infectious Meningitis Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Vaccine for Non-infectious Meningitis Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Vaccine for Non-infectious Meningitis Market Dynamics
  1. 2.1 Vaccine for Non-infectious Meningitis Industry Trends
  2. 2.2 Vaccine for Non-infectious Meningitis Industry Drivers
  3. 2.3 Vaccine for Non-infectious Meningitis Industry Opportunities and Challenges
  4. 2.4 Vaccine for Non-infectious Meningitis Industry Restraints
3 Vaccine for Non-infectious Meningitis Market by Manufacturers
  1. 3.1 Global Vaccine for Non-infectious Meningitis Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Vaccine for Non-infectious Meningitis Sales by Manufacturers (2021-2026)
  3. 3.3 Global Vaccine for Non-infectious Meningitis Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Vaccine for Non-infectious Meningitis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vaccine for Non-infectious Meningitis Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Vaccine for Non-infectious Meningitis Manufacturers, Product Type & Application
  7. 3.7 Global Vaccine for Non-infectious Meningitis Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vaccine for Non-infectious Meningitis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vaccine for Non-infectious Meningitis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vaccine for Non-infectious Meningitis Tier 1, Tier 2, and Tier 3
4 Vaccine for Non-infectious Meningitis Market by Type
  1. 4.1 Vaccine for Non-infectious Meningitis Type Introduction
  2. 4.1.1 Men B Vaccines
  3. 4.1.2 Combination Vaccines
  4. 4.1.3 Conjugate Vaccines
  5. 4.1.4 Polysaccharide Vaccines
  6. 4.2 Global Vaccine for Non-infectious Meningitis Sales by Type
  7. 4.2.1 Global Vaccine for Non-infectious Meningitis Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Vaccine for Non-infectious Meningitis Sales by Type (2021-2032)
  9. 4.2.3 Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2021-2032)
  10. 4.3 Global Vaccine for Non-infectious Meningitis Revenue by Type
  11. 4.3.1 Global Vaccine for Non-infectious Meningitis Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Vaccine for Non-infectious Meningitis Revenue by Type (2021-2032)
  13. 4.3.3 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2021-2032)
5 Vaccine for Non-infectious Meningitis Market by Application
  1. 5.1 Vaccine for Non-infectious Meningitis Application Introduction
  2. 5.1.1 Meningitis
  3. 5.1.2 Septicemia
  4. 5.1.3 Others
  5. 5.2 Global Vaccine for Non-infectious Meningitis Sales by Application
  6. 5.2.1 Global Vaccine for Non-infectious Meningitis Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vaccine for Non-infectious Meningitis Sales by Application (2021-2032)
  8. 5.2.3 Global Vaccine for Non-infectious Meningitis Sales Market Share by Application (2021-2032)
  9. 5.3 Global Vaccine for Non-infectious Meningitis Revenue by Application
  10. 5.3.1 Global Vaccine for Non-infectious Meningitis Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Vaccine for Non-infectious Meningitis Revenue by Application (2021-2032)
  12. 5.3.3 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2021-2032)
6 Global Vaccine for Non-infectious Meningitis Sales by Region
  1. 6.1 Global Vaccine for Non-infectious Meningitis Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vaccine for Non-infectious Meningitis Sales by Region (2021-2032)
  3. 6.2.1 Global Vaccine for Non-infectious Meningitis Sales by Region (2021-2026)
  4. 6.2.2 Global Vaccine for Non-infectious Meningitis Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Vaccine for Non-infectious Meningitis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Vaccine for Non-infectious Meningitis Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Vaccine for Non-infectious Meningitis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Vaccine for Non-infectious Meningitis Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Vaccine for Non-infectious Meningitis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Vaccine for Non-infectious Meningitis Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Vaccine for Non-infectious Meningitis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Vaccine for Non-infectious Meningitis Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Vaccine for Non-infectious Meningitis Revenue by Region
  1. 7.1 Global Vaccine for Non-infectious Meningitis Revenue by Region
  2. 7.1.1 Global Vaccine for Non-infectious Meningitis Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Vaccine for Non-infectious Meningitis Revenue by Region (2021-2026)
  4. 7.1.3 Global Vaccine for Non-infectious Meningitis Revenue by Region (2027-2032)
  5. 7.1.4 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Vaccine for Non-infectious Meningitis Revenue (2021-2032)
  8. 7.2.2 North America Vaccine for Non-infectious Meningitis Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Vaccine for Non-infectious Meningitis Revenue (2021-2032)
  11. 7.3.2 Europe Vaccine for Non-infectious Meningitis Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Vaccine for Non-infectious Meningitis Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Vaccine for Non-infectious Meningitis Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Vaccine for Non-infectious Meningitis Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Vaccine for Non-infectious Meningitis Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 JN-International Medical
  2. 8.1.1 JN-International Medical Company Information
  3. 8.1.2 JN-International Medical Business Overview
  4. 8.1.3 JN-International Medical Vaccine for Non-infectious Meningitis Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 JN-International Medical Vaccine for Non-infectious Meningitis Product Portfolio
  6. 8.1.5 JN-International Medical Recent Developments
  7. 8.2 Nuron Biotech
  8. 8.2.1 Nuron Biotech Company Information
  9. 8.2.2 Nuron Biotech Business Overview
  10. 8.2.3 Nuron Biotech Vaccine for Non-infectious Meningitis Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Nuron Biotech Vaccine for Non-infectious Meningitis Product Portfolio
  12. 8.2.5 Nuron Biotech Recent Developments
  13. 8.3 Serum Institute
  14. 8.3.1 Serum Institute Company Information
  15. 8.3.2 Serum Institute Business Overview
  16. 8.3.3 Serum Institute Vaccine for Non-infectious Meningitis Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Serum Institute Vaccine for Non-infectious Meningitis Product Portfolio
  18. 8.3.5 Serum Institute Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Vaccine for Non-infectious Meningitis Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Vaccine for Non-infectious Meningitis Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Sanofi SA
  26. 8.5.1 Sanofi SA Company Information
  27. 8.5.2 Sanofi SA Business Overview
  28. 8.5.3 Sanofi SA Vaccine for Non-infectious Meningitis Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi SA Vaccine for Non-infectious Meningitis Product Portfolio
  30. 8.5.5 Sanofi SA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vaccine for Non-infectious Meningitis Value Chain Analysis
  2. 9.1.1 Vaccine for Non-infectious Meningitis Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vaccine for Non-infectious Meningitis Production Mode & Process
  6. 9.2 Vaccine for Non-infectious Meningitis Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vaccine for Non-infectious Meningitis Distributors
  9. 9.2.3 Vaccine for Non-infectious Meningitis Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst